What is Emm?
Led by CEO Jenny Button, Emm is a specialized biowearable technology company dedicated to transforming the management of menstrual health. The firm has developed a sophisticated wearable solution that utilizes medical-grade silicone and integrated sensor technology to provide users with precise, objective measurements of menstrual flow volume. Beyond simple tracking, the device monitors critical cycle metrics, including duration, frequency, and regularity, effectively bridging the gap between consumer-grade wearables and clinical-grade health diagnostics. By prioritizing user privacy and data integrity, Emm addresses a significant market void, offering a comprehensive tool for individuals to gain actionable health insights while maintaining full control over their personal biological data.
How much funding has Emm raised?
Emm has raised a total of $10.1M across 2 funding rounds:
Other Financing Round
$1.1M
Seed
$9M
Other Financing Round (2022): $1.1M with participation from Innovate UK
Seed (2025): $9M led by Blue Lion Global, Alumni Ventures, Lunar Ventures, and Labcorp
Key Investors in Emm
Labcorp
Labcorp is a global laboratory services leader providing diagnostic and biopharma laboratory services to help healthcare providers and patients make informed medical decisions.
Lunar Ventures
Lunar Ventures is a prominent European deep-tech fund that supports technical founders with long-term capital and expertise in complex infrastructure and science-based technologies.
Blue Lion Global
Blue Lion Global is an investment group focused on backing early-stage startups across the US and Europe that address significant societal challenges in health and energy.
What's next for Emm?
With the successful closure of this major strategic investment, Emm is well-positioned to scale its operations and enhance its technological infrastructure. The company's roadmap likely includes the optimization of its sensor algorithms to improve diagnostic accuracy and the potential expansion of its market reach into broader health-tech ecosystems. Given the involvement of strategic partners like Labcorp, Emm may also explore clinical validation pathways or integration opportunities within existing healthcare diagnostic frameworks. As the company transitions from its current development phase toward broader commercialization, the focus will remain on scaling production, deepening its data analytics capabilities, and solidifying its reputation as a leader in the intersection of wearable hardware and women's health diagnostics.
See full Emm company page
